Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Thaler’s JAT Capital Management Fund Up 31% YTD

John Thaler’s JAT Capital Management fund is up 31% through the end of September, according to Bloomberg.

How Did John Thaler Do It?

Considering Bloomberg reports that “hedge funds on average dropped 0.9 percent in the year’s first nine months and long-short managers posted losses of 2.6 percent,” Thaler’s performance is extraordinary. Several people familiar with the matter explained that Thaler’s neutral stance and short positions drove the above-average returns. Apparently, the fund manager had a variety of short positions, so he was able to turn a profit when those stocks fell and offset any losses his fund incurred owing to his long positions. In other words, Thaler seeks to avoid huge fluctuations in his JAT Capital Management’s portfolio by betting “on both sides of the book.”

Who is John Thaler?

John Thaler is only 36. He received a BS in economics at the University of Chicago and went straight into working as an analyst at Merrill Lynch & Co., and later as an associate at Spectrum Equity Investors LP. Thaler went on to join Chris Shumway’s Shumway Capital Partners LLC when Shumway started the group in 2002. Here, Thaler worked as an analyst in telecommunications, media and technology, eventually progressing to manage the SCP Omni Fund. He left in 2007 to start his own hedge fund. In November that year, he founded JAT Capital Management. Thaler started the fund with over $220 million in assets, including some start-up capital from Shumway.


Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!